Accelerating the search for antimicrobial peptides with Google Antigravity
deepmind.google·2h ago
AI Engineering
MIT Technology Review·1d ago·5 min read
The Download: faking blood and the future of batteries
TL;DR
The US military is advancing research into synthetic blood to enhance battlefield medical response, aiming to save lives in critical situations. This initiative follows a tragic incident in 2007 where a helicopter carrying blood was shot down, highlighting the need for alternatives.
✦ Why It Matters
Consider supporting or investing in synthetic blood research initiatives to enhance emergency medical responses.
Key Takeaways
- Investigate synthetic biology for medical applications.
- Stay updated on DARPA's progress in synthetic blood.
- Consider implications of synthetic alternatives in healthcare.
- Explore partnerships with military or medical research organizations.
Full Summary
In response to the risks associated with transporting blood to battlefield hospitals, particularly highlighted by a tragic incident in 2007, DARPA is spearheading a $73 million project to create synthetic blood products. The goal is to develop dried versions of plasma, platelets, and red blood cells that can be stored for extended periods and rapidly deployed when needed.
Researchers are currently grappling with significant questions regarding the safety and effectiveness of these synthetic alternatives. The project aims to have these dried blood products ready for field use by 2029, but achieving this timeline presents considerable scientific and logistical challenges.
If successful, this initiative could revolutionize emergency medical care in military settings, potentially saving lives by ensuring immediate access to blood products.